Amylyx Pharmaceuticals, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
AMLX Nasdaq 2830 amylyx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Amylyx Pharmaceuticals, Inc.

Amylyx Pharmaceuticals (AMLX) Valuation Check As New GLP-1 Candidate AMX0318 Enters Development Stage - Jan 11th, 2026 11:09 am
Amylyx Pharmaceuticals (AMLX) Announces the Selection of AMX0318 as Development Candidate for PBH and Other Rare Diseases - Jan 10th, 2026 12:57 pm
Amylyx selects AMX0318 as development candidate for PBH - Jan 9th, 2026 5:16 am
Amylyx Pharmaceuticals Announces Nomination of AMX0318 as a Novel, Long-Acting GLP-1 Receptor Antagonist Development Candidate, Identified in Collaboration with Gubra A/S - Jan 8th, 2026 5:00 am
Amylyx pins its next hopes on a niche drug in the obesity space - Dec 12th, 2025 2:35 am
Is Early AMX0114 Safety Data Altering The Investment Case For Amylyx Pharmaceuticals (AMLX)? - Dec 9th, 2025 4:12 pm
Hedge Fund Boosts Stake in Amylyx Stock to $63 Million — Should Investors Follow? - Dec 9th, 2025 5:20 am
Amylyx Pharmaceuticals Announces New Safety and Tolerability Cohort 1 Data of AMX0114 in ALS from First-in-Human LUMINA Trial - Dec 5th, 2025 7:00 am
With a 150% Rally and Big 2026 Catalysts Ahead, Is Amylyx Stock Getting a Second Chance? - Dec 3rd, 2025 8:05 am
Is Exact Sciences (EXAS) Stock Outpacing Its Medical Peers This Year? - Nov 10th, 2025 7:40 am
Amylyx Pharmaceuticals (AMLX): Assessing Valuation After a Sharp Rally and Recent Pullback - Nov 10th, 2025 3:14 am
Amylyx Pharmaceuticals Inc (AMLX) Q3 2025 Earnings Call Highlights: Strong Cash Position and ... - Nov 6th, 2025 12:12 pm
Amylyx Pharmaceuticals Reports Third Quarter 2025 Financial Results - Nov 6th, 2025 5:00 am
Amylyx Pharmaceuticals to Present at Upcoming Investor Conferences - Nov 3rd, 2025 7:00 am
Amylyx Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025 - Oct 30th, 2025 7:00 am
Amylyx Pharmaceuticals (AMLX): Assessing Valuation After a Dramatic 260% Share Price Surge - Oct 26th, 2025 10:10 am
BofA Securities Lifts Amylyx Pharmaceuticals Inc. (AMLX) Price Target Amid Bolstered Balance Sheet - Oct 26th, 2025 4:16 am
What Makes Amylyx Pharmaceuticals, Inc. (AMLX) a Strong Momentum Stock: Buy Now? - Oct 24th, 2025 10:00 am
Wall Street Analysts See a 29.28% Upside in Amylyx Pharmaceuticals (AMLX): Can the Stock Really Move This High? - Oct 24th, 2025 7:55 am
Has Amylyx Pharmaceuticals (AMLX) Outpaced Other Medical Stocks This Year? - Oct 24th, 2025 7:40 am